Weight-Loss Drug Market Can Hit 0 Billion, J.P. Morgan Says. Eli Lilly Is a Big Winner.

[ad_1]

Eli Lilly


could reach $50 billion in annual sales from weight-loss drugs by 2030, making the pharmaceutical company one of the big winners from obesity treatments,

J.P. Morgan


[ad_2]

Source link